Acquisition by Leonard Braden Michael of 806 shares of Reneo Pharmaceuticals at 1.4 subject to Rule 16b-3
RPHMDelisted Stock | USD 18.20 1.40 8.33% |
About 55% of RPHM Old's investors are presently thinking to get in. The analysis of current outlook of investing in RPHM Old suggests that some traders are interested regarding RPHM Old's prospects. RPHM Old's investing sentiment overview a quick insight into current market opportunities from investing in RPHM Old. Many technical investors use RPHM Old stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
RPHM |
Filed transaction by Reneo Pharmaceuticals 10 Percent Owner. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
RPHM Old Fundamental Analysis
We analyze RPHM Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of RPHM Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of RPHM Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
RPHM Old is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
RPHM Old Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with RPHM Old stock to make a market-neutral strategy. Peer analysis of RPHM Old could also be used in its relative valuation, which is a method of valuing RPHM Old by comparing valuation metrics with similar companies.
Peers
RPHM Old Related Equities
SMMT | Summit Therapeutics | 16.13 | ||||
DNA | Ginkgo Bioworks | 6.93 | ||||
LEGN | Legend Biotech | 6.15 | ||||
CNSP | Cns Pharmaceuticals | 5.60 | ||||
EWTX | Edgewise Therapeutics | 4.30 | ||||
VIR | Vir Biotechnology | 3.07 | ||||
CELC | Celcuity LLC | 2.56 | ||||
HOWL | Werewolf Therapeutics | 2.26 | ||||
KZR | Kezar Life | 2.26 | ||||
CGEM | Cullinan Oncology | 1.56 | ||||
PRME | Prime Medicine, | 1.04 | ||||
KRON | Kronos Bio | 0.98 | ||||
APLS | Apellis Pharmaceuticals | 0.63 | ||||
ADPT | Adaptive Biotechnologies | 0.00 | ||||
RPRX | Royalty Pharma | 0.00 | ||||
NKTX | Nkarta | 1.21 | ||||
CCCC | C4 Therapeutics | 2.28 | ||||
IMMX | Immix Biopharma | 3.43 | ||||
OCEA | Ocean Biomedical | 10.83 | ||||
HEPA | Hepion Pharmaceuticals | 31.53 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Consideration for investing in RPHM Stock
If you are still planning to invest in RPHM Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RPHM Old's history and understand the potential risks before investing.
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |